Clinical Trial Update: Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the use of procalcitonin levels to guide stopping antibiotics in ICU patients with no obvious site of infection was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infection
• Infection
• Sepsis

Snippet

Sponsor: Brahms AG | Conditions: Infection, Bacterial Infection | Phase 4 | Status: TERMINATED